BR0002763B1 - composiÇço cosmÉtica tàpica para emagrecimento À base de um derivado de l-arginina ou um de seus sais. - Google Patents

composiÇço cosmÉtica tàpica para emagrecimento À base de um derivado de l-arginina ou um de seus sais.

Info

Publication number
BR0002763B1
BR0002763B1 BRPI0002763-4A BR0002763A BR0002763B1 BR 0002763 B1 BR0002763 B1 BR 0002763B1 BR 0002763 A BR0002763 A BR 0002763A BR 0002763 B1 BR0002763 B1 BR 0002763B1
Authority
BR
Brazil
Prior art keywords
salts
composition based
arginine derivative
typical cosmetic
slimming composition
Prior art date
Application number
BRPI0002763-4A
Other languages
English (en)
Other versions
BR0002763A (pt
Inventor
Marie-Christine Seguin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0002763A publication Critical patent/BR0002763A/pt
Publication of BR0002763B1 publication Critical patent/BR0002763B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0002763-4A 1999-06-16 2000-06-15 composiÇço cosmÉtica tàpica para emagrecimento À base de um derivado de l-arginina ou um de seus sais. BR0002763B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907631A FR2794974B1 (fr) 1999-06-16 1999-06-16 Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique

Publications (2)

Publication Number Publication Date
BR0002763A BR0002763A (pt) 2001-01-30
BR0002763B1 true BR0002763B1 (pt) 2013-05-07

Family

ID=9546881

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0002763-4A BR0002763B1 (pt) 1999-06-16 2000-06-15 composiÇço cosmÉtica tàpica para emagrecimento À base de um derivado de l-arginina ou um de seus sais.

Country Status (8)

Country Link
US (1) US6716436B1 (pt)
EP (1) EP1060739B1 (pt)
JP (1) JP4833394B2 (pt)
CN (1) CN1159003C (pt)
AR (1) AR024364A1 (pt)
BR (1) BR0002763B1 (pt)
ES (1) ES2416280T3 (pt)
FR (1) FR2794974B1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
JP2002193782A (ja) * 2000-12-22 2002-07-10 Shiyuu Uemura Keshohin:Kk 皮膚化粧料
MC200058A1 (fr) 2002-04-05 2003-01-30 A M Exsymol S Analogues du dipeptide citrullinylarginine et leurs utilisations dermatologiques comme agents de soin et de traitement
FR2851461B1 (fr) * 2003-02-21 2007-04-20 Seppic Sa Utilisation de n-octanoyl aminoacides comme actif cosmetique et pharmaceutique amincissant
FR2851460B1 (fr) * 2003-02-21 2007-05-11 Seppic Sa Utilisation de n-lauroyl aminoacides comme actif cosmetique et pharmaceutique amincissant
EP1732577B1 (en) * 2004-02-23 2013-04-10 Strategic Science & Technologies, LLC Topical delivery of l-arginine to improve body and skin appearance
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
JP2007532697A (ja) 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
HUP0401422A2 (en) 2004-07-15 2006-04-28 G Laszlo Meszaros Use of l-arginine as vasoaktive ingredient absorbing through skin for external application
FR2876004B1 (fr) * 2004-10-01 2007-04-06 Exsymol Sa Monegasque Utilisation d'algues rouges soumises a des conditions extremes de temperature et de luminosite
EP1828109B1 (en) * 2004-11-12 2013-06-05 UCL Business PLC Guanidine derivatives as inhibitors of ddah
CN101674853B (zh) 2007-05-04 2013-03-27 玛瑞纳生物技术有限公司 氨基酸脂质及其用途
FR2929118B1 (fr) 2008-03-28 2010-05-07 Oreal Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
JP4638963B2 (ja) * 2008-04-07 2011-02-23 敏 新川 痩身用化粧品組成物
FR2943253B1 (fr) 2009-03-20 2011-04-22 Oreal Composition contenant l'association de madecassoside, d'une arginine et de polysorbate
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US9072659B2 (en) 2009-06-24 2015-07-07 Strategic Science & Technologies, Llc Topical composition containing naproxen
AU2009348470B2 (en) * 2009-06-24 2015-04-02 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
EP2658551B1 (en) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Treatment of erectile dysfunction and other indications
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
FR3012958B1 (fr) * 2013-11-08 2016-01-01 Oreal Compositions cosmetiques comprenant de l'acide spiculisporique et au moins un tensioactif sulfate et/ou sulfonate
FR3023477B1 (fr) * 2014-07-10 2017-11-24 Oreal Utilisation cosmetique de l'acide spiculisporique comme actif deodorant
FR3117834B1 (fr) 2020-12-17 2023-11-10 Oreal Composition cosmétique biphase comprenant un acide aminé et deux acides spécifiques

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR958M (pt) * 1961-01-18 1961-11-27
EP0009010B1 (en) * 1978-07-18 1983-03-02 Kabi AB Bradykinin inhibiting tripeptide derivatives, process for their preparation and pharmaceutical preparations containing them
DE3538749A1 (de) * 1985-10-31 1987-05-07 Merck Patent Gmbh Peptide
GB2199243A (en) * 1986-09-17 1988-07-06 Natural Vitality Ltd Pharmaceutical compositions comprising ornithine and arginine
FR2610522B1 (fr) * 1987-02-06 1989-08-18 Gueyne Jean Produit therapeutique a base de derives organiques du silicium
US4885157A (en) * 1987-02-13 1989-12-05 Fiaschetti Mary G Dermal cosmetic composition and applications therefor
FR2611496B1 (fr) * 1987-03-04 1992-07-03 Gueyne Jean Organo-silicies cosmetiques
LU87390A1 (fr) * 1988-11-17 1990-06-12 Oreal Utilisation du nicotinate d'alpha-tocopherol et/ou du nicotinate d'hexyle dans une composition cosmetique a action amincissante
FR2680686B1 (fr) * 1991-08-28 1993-11-05 Oreal Lotion tri-phases destinee a un usage corporel, pharmaceutique ou cosmetique.
JPH06199626A (ja) * 1992-12-28 1994-07-19 Yamakawa Boeki Kk 新規なオリゴペプチド含有美容製品調製用添加剤
US5364884A (en) * 1993-01-21 1994-11-15 Baylor College Of Medicine Arginine compounds as ocular hypotensive agents
FR2701948B1 (fr) * 1993-02-22 1996-07-26 Exsymol Sa Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires.
JPH0733635A (ja) * 1993-07-21 1995-02-03 Kao Corp 皮膚外用剤
DE4341001A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Topische Zubereitungen mit einem Gehalt an L-Arginin
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
US5830866A (en) * 1994-09-12 1998-11-03 The Trustees Of The University Of Pennsylvania Corticotropin release inhibiting factor and methods of using same
US6211154B1 (en) * 1995-06-07 2001-04-03 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
FR2745498A1 (fr) * 1996-02-29 1997-09-05 Giroux Jean Marc Composition pur augmenter conjointement la tolerance biologique et l'efficacite amincissante des produits hyperproteines hypocaloriques destines au traitement de l'obesite
JP4020989B2 (ja) * 1996-03-06 2007-12-12 株式会社ノエビア 血流促進剤及びこれを配合して成る皮膚外用剤
JPH10101546A (ja) * 1996-09-27 1998-04-21 Shiseido Co Ltd 皮膚外用剤
FR2758724B1 (fr) * 1997-01-24 1999-04-23 Javenech Composition topique a base de protamine pour le traitement de la cellulite et des surcharges ponderales
JP2001512471A (ja) * 1997-02-21 2001-08-21 バイヤースドルフ・アクチエンゲゼルシヤフト しゅさの処置のための調製物
FR2761074B1 (fr) * 1997-03-24 1999-05-28 Exsymol Sa Composes a base de silicium biologiquement actifs sous forme solide
CA2303394C (en) * 1997-09-17 2011-12-20 Strategic Science & Technologies, Inc. A delivery of arginine to cause beneficial effects
US5874068A (en) * 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
JPH11269079A (ja) * 1998-03-17 1999-10-05 Shiseido Co Ltd 脂質分解促進用皮膚外用剤
JP3519269B2 (ja) * 1998-03-23 2004-04-12 株式会社資生堂 皮膚外用剤
TR200003384T2 (tr) * 1998-05-18 2001-03-21 Pharmacia & Upjohn Company Arginin türevleri kullanılarak oksazolidinon antibakteriyel maddelerin etkisinin arttırılması
US6159485A (en) * 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
DE19918750A1 (de) * 1999-04-24 2000-10-26 Beiersdorf Ag Wirkstoffe, kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique

Also Published As

Publication number Publication date
ES2416280T3 (es) 2013-07-31
FR2794974A1 (fr) 2000-12-22
CN1159003C (zh) 2004-07-28
BR0002763A (pt) 2001-01-30
FR2794974B1 (fr) 2001-08-17
JP2001026514A (ja) 2001-01-30
CN1283447A (zh) 2001-02-14
EP1060739B1 (fr) 2013-04-03
JP4833394B2 (ja) 2011-12-07
EP1060739A1 (fr) 2000-12-20
US6716436B1 (en) 2004-04-06
AR024364A1 (es) 2002-10-02

Similar Documents

Publication Publication Date Title
BR0002763B1 (pt) composiÇço cosmÉtica tàpica para emagrecimento À base de um derivado de l-arginina ou um de seus sais.
BR0214263B1 (pt) processos para a preparaÇço de uma composiÇço para o tratamento dos cabelos.
IS6957A (is) Tatrat sölt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9,-pentaen og lyfjafræðilegar samsetningar af þeim
NO20012915L (no) Ny farmasöytisk formulering
NO20011738L (no) Heterocyclylaminometyloksazolidinoner som antibakterielle midler
BR8102849Y1 (pt) disposição aplicada à base aperfeiçoada para garrafas com concavidade.
BR0112842B1 (pt) liga com base em alumÍnio e mÉtodo para a fabricaÇço de semiprodutos da mesma.
ATE267178T1 (de) Diazepinderivate oder deren salze
ATE303358T1 (de) Verbindungen mit kalzilytischer wirkung
DK1056448T3 (da) Farmaceutiske kombinationer med tramadol
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
BR0210309B1 (pt) composição para tratamento de roupas a lavar, e, uso da mesma.
FI974099A0 (fi) Dricksburkslock som kan oeppnas med en hand
FR2718021B1 (fr) Composition topique à base de rétinal.
NO20021040D0 (no) Substituerte N-fenyl- 2-hydroksy-2-metyl-3,3,3- trifluoropropanamid-derivater som eleverer puruvatdehydrogenase-aktivitet
BR9707877A (pt) Uso de ácido 2-(3,4-dimetoxi cinamoil) amino benzóico para a fabricação de um medicamento para o tratamento ou prevenã o de restenose
DK1278759T3 (da) Bis-(N,N'-bis-(2-halogenethyl)amino)phoshoramidater som antitumormidler
DK1492781T3 (da) N,N'-disubstituerede piperazinforbindelser og deres anvendelse som smertestillende midler
ES1039821Y (es) Protector para calzados perfeccionado.
ES1040913Y (es) Manipulador de piezas sobre puesto de trabajo.
ES1048764Y (es) Gorron perfeccionado para piezas giratorias de mecanismos de persianas enrollables.
ES1043113Y (es) Pata para somier perfeccionada.
ES1042754Y (es) Clavo `perfeccionado.
ES1048405Y (es) Calendario perfeccionado.
ES1049785Y (es) Calendario perfeccionado.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/05/2013, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/64 (2006.01), A61K 8/44 (2006.01), A61Q 19/

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2594 DE 24-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.